Systems biology of polycystic kidney disease: a critical review

被引：16
|
作者：
Menezes, Luis Fernando [1 ]
Germino, Gregory G. [1 ,2 ]
机构：
[1] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
来源：
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE | 2015年 / 7卷 / 01期
关键词：
CYST FORMATION; GENES; MODEL; IDENTIFICATION; EXPRESSION; PATHWAYS; CELLS; CILIA; PHOSPHORYLATION; PROLIFERATION;
D O I：
10.1002/wsbm.1289
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The proliferation and diminishing costs of 'omics' approaches have finally opened the doors for small and medium laboratories to enter the 'systems biology era'. This is a welcome evolution that requires a new framework to design, interpret, and validate studies. Here, we highlight some of the challenges, contributions, and prospects of the 'cyst-ems biology' of polycystic kidney disease. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
引用
收藏
页码：39 / 52
页数：14
相关论文
共 50 条
  • [41] Netrin-1 Overexpression Induces Polycystic Kidney Disease A Novel Mechanism Contributing to Cystogenesis in Autosomal Dominant Polycystic Kidney Disease
    Mohamed, Riyaz
    Liu, Yang
    Kistler, Andreas D.
    Harris, Peter C.
    Thangaraju, Muthusamy
    AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (06) : 862 - 875
  • [42] Characterization of the polycystic kidney disease 2 gene promoter
    Wang, Qingsong
    Han, Gang
    Ye, Jianhua
    Gao, Xianjun
    Niu, Hongjing
    Zhao, Jingwen
    Chai, Yawen
    Li, Ning
    Yin, HaiFang
    GENOMICS, 2014, 104 (06) : 512 - 519
  • [43] Acromegaly accompanied by diabetes mellitus and polycystic kidney disease
    Otani, Daisuke
    Murakami, Takaaki
    Matsubara, Takeshi
    Hojo, Masato
    Nakae, Takuro
    Moriyoshi, Koki
    Yasoda, Akihiro
    Usui, Ryota
    Tatsuoka, Hisato
    Ogura, Masahito
    Inagaki, Nobuya
    Yamamoto, Taizou
    ENDOCRINE JOURNAL, 2021, 68 (01) : 103 - 110
  • [44] Molecular basis of autosomal dominant polycystic kidney disease
    Al-Bhalal, L
    Akhtar, M
    ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (03) : 126 - 133
  • [45] The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney
    Verghese, Elizabeth
    Johnson, Chad
    Bertram, John F.
    Ricardo, Sharon D.
    Deane, James A.
    BMC NEPHROLOGY, 2012, 13
  • [46] Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
    Podrini, Christine
    Cassina, Laura
    Boletta, Alessandra
    CELLULAR SIGNALLING, 2020, 68
  • [47] Quinomycin A reduces cyst progression in polycystic kidney disease
    Radadiya, Priyanka S.
    Thornton, Mackenzie M.
    Daniel, Emily A.
    Idowu, Jessica Y.
    Wang, Wei
    Magenheimer, Brenda
    Subramaniam, Dharmalingam
    Tran, Pamela, V
    Calvet, James P.
    Wallace, Darren P.
    Sharma, Madhulika
    FASEB JOURNAL, 2021, 35 (05)
  • [48] Macrophages Promote Cyst Growth in Polycystic Kidney Disease
    Karihaloo, Anil
    Koraishy, Farrukh
    Huen, Sarah C.
    Lee, Yashang
    Merrick, David
    Caplan, Michael J.
    Somlo, Stefan
    Cantley, Lloyd G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (10): : 1809 - 1814
  • [49] Drug repurposing in autosomal dominant polycystic kidney disease
    Zhou, Julie Xia
    Torres, Vicente E.
    KIDNEY INTERNATIONAL, 2023, 103 (05) : 859 - 871
  • [50] Functional and systems biology approaches to Huntington's disease
    Gonzalez-Couto, Eduardo
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2011, 10 (03) : 109 - 114
12345